Technical Analysis for AGN - Allergan, Inc.

Grade Last Price % Change Price Change
grade C 172.49 -1.54% -2.70
AGN closed down 1.54 percent on Thursday, June 21, 2018, on 44 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Flat Up Flat
See historical AGN trend table...

Date Alert Name Type % Chg
Jun 21 Downside 200 DMA Break Bearish 0.00%
Jun 21 Slingshot Bullish Bullish Swing Setup 0.00%
Jun 21 Overbought Stochastic Strength 0.00%
Jun 20 New Uptrend Bullish -1.54%
Jun 20 Upside 200 DMA Break Bullish -1.54%
Jun 20 Gapped Up Strength -1.54%
Jun 20 Overbought Stochastic Strength -1.54%
Jun 19 Stochastic Sell Signal Bearish -0.32%
Jun 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.32%
Jun 19 Multiple of Ten Bullish Other -0.32%

Older signals for AGN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and over-the-counter skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. It focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, urologists, and general practitioners. The company has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Is AGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 253.8791
52 Week Low 142.81
Average Volume 2,845,201
200-Day Moving Average 172.8581
50-Day Moving Average 158.9372
20-Day Moving Average 163.0105
10-Day Moving Average 172.216
Average True Range 4.5206
ADX 25.88
+DI 31.87
-DI 16.86
Chandelier Exit (Long, 3 ATRs ) 165.1982
Chandelier Exit (Short, 3 ATRs ) 160.5918
Upper Bollinger Band 182.2144
Lower Bollinger Band 143.8066
Percent B (%b) 0.75
BandWidth 23.56155
MACD Line 5.0281
MACD Signal Line 3.8925
MACD Histogram 1.1356
Fundamentals Value
Market Cap 57.66 Billion
Num Shares 334 Million
EPS 32.82
Price-to-Earnings (P/E) Ratio 5.26
Price-to-Sales 3.91
Price-to-Book 0.84
PEG Ratio 0.97
Dividend 2.80
Dividend Yield 1.62%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 177.89
Resistance 3 (R3) 178.29 176.89 176.99
Resistance 2 (R2) 176.89 175.51 176.69 176.69
Resistance 1 (R1) 174.69 174.67 173.99 174.29 176.39
Pivot Point 173.29 173.29 172.94 173.09 173.29
Support 1 (S1) 171.09 171.91 170.39 170.69 168.59
Support 2 (S2) 169.69 171.07 169.49 168.29
Support 3 (S3) 167.49 169.69 167.99
Support 4 (S4) 167.09